KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Prepaid Assets (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Prepaid Assets for 8 consecutive years, with $45.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 5.41% to $45.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.1 million through Dec 2025, down 5.41% year-over-year, with the annual reading at $45.1 million for FY2025, 5.41% down from the prior year.
  • Prepaid Assets hit $45.1 million in Q4 2025 for Vir Biotechnology, up from $37.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $85.7 million in Q2 2023 to a low of $1.0 million in Q2 2024.
  • Historically, Prepaid Assets has averaged $40.5 million across 5 years, with a median of $41.5 million in 2025.
  • Biggest five-year swings in Prepaid Assets: plummeted 98.83% in 2024 and later surged 4046.9% in 2025.
  • Year by year, Prepaid Assets stood at $73.0 million in 2021, then tumbled by 63.84% to $26.4 million in 2022, then plummeted by 71.21% to $7.6 million in 2023, then soared by 527.96% to $47.7 million in 2024, then dropped by 5.41% to $45.1 million in 2025.
  • Business Quant data shows Prepaid Assets for VIR at $45.1 million in Q4 2025, $37.0 million in Q3 2025, and $41.5 million in Q2 2025.